Cardinal Health (CAH)
(Delayed Data from NYSE)
$112.55 USD
+0.57 (0.51%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $112.56 +0.01 (0.01%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$112.55 USD
+0.57 (0.51%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $112.56 +0.01 (0.01%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth B Momentum A VGM
Zacks News
Here's Why Cardinal Health (CAH) is a Strong Momentum Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cardinal Health (CAH) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
In the closing of the recent trading day, Cardinal Health (CAH) stood at $111.92, denoting a -0.52% change from the preceding trading day.
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Aveanna Healthcare (AVAH) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Aveanna Healthcare (AVAH) and Cardinal Health (CAH) have performed compared to their sector so far this year.
CAH Stock May Gain Following the Distribution Deal With T2 Biosystems
by Zacks Equity Research
Cardinal Health and T2 Biosystems announce an agreement selecting the former to sell direct-from-blood diagnostics for the rapid detection of sepsis-causing pathogens.
Cardinal Health (CAH) Stock Moves -0.2%: What You Should Know
by Zacks Equity Research
The latest trading day saw Cardinal Health (CAH) settling at $111.76, representing a -0.2% change from its previous close.
Reasons to Retain Cardinal Health Stock in Your Portfolio Now
by Zacks Equity Research
CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
Cardinal Health (CAH) Stock Moves -0.17%: What You Should Know
by Zacks Equity Research
Cardinal Health (CAH) closed at $110.33 in the latest trading session, marking a -0.17% move from the prior day.
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cardinal Health (CAH) Dips More Than Broader Market: What You Should Know
by Zacks Equity Research
In the most recent trading session, Cardinal Health (CAH) closed at $108.82, indicating a -1.24% shift from the previous trading day.
Cardinal Health Stock Likely to Gain From the Acquisition of ION
by Zacks Equity Research
CAH is set to acquire Oncology Network for $1.115 billion, expanding its oncology offerings while supporting community-based cancer care across 10 states.
Is Applied Therapeutics (APLT) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Applied Therapeutics Inc. (APLT) and Cardinal Health (CAH) have performed compared to their sector so far this year.
Is Cardinal Health (CAH) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cardinal Health (CAH) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
Cardinal Health (CAH) reachead $110.76 at the closing of the latest trading day, reflecting a -0.58% change compared to its last close.
CAH Stock May Gain Following the Distribution Agreement With Telix
by Zacks Equity Research
Cardinal Health and Telix announce an agreement selecting the former as a commercial radiopharmaceutical distributor to supply finished unit doses of Telix's Zircaix.
Why Cardinal Health (CAH) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Cardinal Health (CAH) Gained But Lagged the Market Today
by Zacks Equity Research
In the latest trading session, Cardinal Health (CAH) closed at $113.28, marking a +0.1% move from the previous day.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Cardinal Health (CAH) Advances But Underperforms Market: Key Facts
by Zacks Equity Research
The latest trading day saw Cardinal Health (CAH) settling at $112.80, representing a +0.92% change from its previous close.
Reasons to Retain Cardinal Health Stock in Your Portfolio Now
by Zacks Equity Research
CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
Greenville Center to Boost CAH Stock's at-Home Solution Business
by Zacks Equity Research
Cardinal Health announces the opening of its new distribution center in Greenville to support its at-Home Solutions business.
Zacks Investment Ideas feature highlights: Cardinal Health, Taiwan Semiconductor and Altria
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Cardinal Health, Taiwan Semiconductor and Altria.
3 Consistent Dividend Growers to Buy for Passive Income: TSM, MO, CAH
by Derek Lewis
For those seeking companies with a consistent history of steady payouts, all three of these stocks fit the criteria. Who doesn't like payday?
Cardinal Health (CAH) to Open New Distribution Center in Ohio
by Zacks Equity Research
Cardinal Health's (CAH) new center is set to integrate cutting-edge technology and automation, enhancing efficiency, storage capacity and quality of service.
Zacks Investment Ideas feature highlights: Walmart, Cardinal Health and Eli Lilly
by Zacks Equity Research
Walmart, Cardinal Health and Eli Lilly have been highlighted in this Investment Ideas article.